Baseten launches a new AI training infrastructure platform that gives developers full control, slashes inference costs by up ...

Learn why developers choose Liquid Web’s GPU hosting for AI healthcare apps that demand speed, scalability, and HIPAA-ready ...

Learn how to fine-tune AI models for your unique needs with this easy-to-follow guide. Simplify AI customization and achieve ...

The vibe coding tool Cursor, from startup Anysphere, has introduced Composer, its first in-house, proprietary coding large language model (LLM) as part of its Cursor 2.0 platform update.

Metro-North Railroad will soon connect New York City to Upstate New York with the debut of a daily round trip between Grand Central Terminal and Albany. Starting in spring 2026, MTA Metro-North trains ...

LOS ANGELES — New questions are emerging about why there were no public warnings before the U.S. Marines fired over Interstate 5 and a major regional commuter rail line as a test run a day before the ...

This is read by an automated voice. Please report any issues or inconsistencies here. U.S. Marines fired 30 artillery shells over Interstate 5 and train tracks Friday during rush hour without public ...

The news of Eurostar’s order of double-decker trains means everyone that wants to increase international services from London has announced what sets they will use. The news of Eurostar’s order of ...

OpenAI has formed a new team of over 100 former investment bankers under a new initiative internally called “Project Mercury.” The project pays contractors, many of whom are former employees of ...

The president of New Mexico State University and a prominent Japanese tech company signed an agreement Monday enabling the creation of a testing ground for the company’s latest technologies at the ...

Adobe assures its new AI model service is copyright-safe. Foundry models leverage Firefly and are trained on brands' IP. Tech companies are racing to deliver personalizable AI tools. In the age of ...

Grail is on a mission to have its cancer blood test become a core part of U.S. screening for a range of tumors. Now, it’s detailing its latest data as it heads to the FDA. Back in June, Grail revealed ...